Steven M. Rowe, M.D., MSPH, has been named director of the Gregory Fleming James Cystic Fibrosis Research Center in the UAB School of Medicine, effective Aug. 1.
Grandmother’s vision struggle motivates young woman to make a difference
Written by Megan McSwain Yeatts
As a young girl in Afghanistan, Fazila Aseem watched her grandmother struggle to complete daily tasks independently due to vision loss. This summer, Aseem will work with researchers in the Department of Ophthalmology to continue her interest in aging and vision research.
UAB is set to open a mental health clinic July 20 that will improve access to care for those who identify as LGBTQ.
Monika M. Safford, M.D., helped shape the new Web tool for the National Diabetes Education Program, “Promoting Medication Adherence in Diabetes.”
UAB’s ongoing research for countermeasures to bromine or chlorine exposure — from either industrial spills or chemical attack — gets a boost with a new NIH grant.
UAB’s Candace Floyd is set to take a top leadership post with the National Neurotrauma Society.
Fishing for new ways to stop Parkinson’s, a researcher makes big catches in the gene pool
Written by Matt Windsor
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
UAB study finds that seniors in subsidized housing have higher rates of vision impairment
Written by Bob Shepard
Rates of vision impairment are high among seniors living in subsidized housing, suggesting an increased need for widespread vision screening.
Birmingham woman part of verapamil diabetes trial, learning to live with new diagnosis
Written by Tyler Greer
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.